301 related articles for article (PubMed ID: 7706817)
1. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
Chambers HF; Kartalija M; Sande M
J Infect Dis; 1995 Apr; 171(4):897-902. PubMed ID: 7706817
[TBL] [Abstract][Full Text] [Related]
2. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.
Ramos MC; Ing M; Kim E; Witt MD; Bayer AS
Antimicrob Agents Chemother; 1996 Jan; 40(1):97-101. PubMed ID: 8787887
[TBL] [Abstract][Full Text] [Related]
3. Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam.
Backo M; Gaenger E; Burkart A; Chai YL; Bayer AS
Antimicrob Agents Chemother; 1999 Oct; 43(10):2565-8. PubMed ID: 10508047
[TBL] [Abstract][Full Text] [Related]
4. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
Pefanis A; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
Antimicrob Agents Chemother; 1993 Mar; 37(3):507-11. PubMed ID: 8460919
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM
Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of cefoperazone in combination with sulbactam in experimental Staphylococcus aureus endocarditis in rabbits.
Chambers HF; Fournier MA
J Antimicrob Chemother; 1993 Sep; 32(3):453-8. PubMed ID: 8262867
[TBL] [Abstract][Full Text] [Related]
7. Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis.
Perdikaris G; Giamarellou H; Pefanis A; Donta I; Karayiannakos P
Antimicrob Agents Chemother; 1995 Oct; 39(10):2289-94. PubMed ID: 8619584
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Madrigal AG; Basuino L; Chambers HF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
Bayer AS; Lam K
J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588
[TBL] [Abstract][Full Text] [Related]
10. Importance of penicillinase production for activity of penicillin alone or in combination with sulbactam in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Fantin B; Pierre J; Castéla-Papin N; Saint-Julien L; Drugeon H; Farinotti R; Carbon C
Antimicrob Agents Chemother; 1996 May; 40(5):1219-24. PubMed ID: 8723470
[TBL] [Abstract][Full Text] [Related]
11. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.
Hiramatsu K; Hanaki H; Ino T; Yabuta K; Oguri T; Tenover FC
J Antimicrob Chemother; 1997 Jul; 40(1):135-6. PubMed ID: 9249217
[No Abstract] [Full Text] [Related]
12. Evaluation of ceftobiprole in a rabbit model of aortic valve endocarditis due to methicillin-resistant and vancomycin-intermediate Staphylococcus aureus.
Chambers HF
Antimicrob Agents Chemother; 2005 Mar; 49(3):884-8. PubMed ID: 15728879
[TBL] [Abstract][Full Text] [Related]
13. Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis.
Brandt CM; Rouse MS; Tallan BM; Laue NW; Wilson WR; Steckelberg JM
Antimicrob Agents Chemother; 1995 Aug; 39(8):1815-9. PubMed ID: 7486924
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
Thauvin-Eliopoulos C; Rice LB; Eliopoulos GM; Moellering RC
Antimicrob Agents Chemother; 1990 May; 34(5):728-32. PubMed ID: 2360813
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and pharmacodynamics of linezolid, alone and in combination with rifampicin, in an experimental model of methicillin-resistant Staphylococcus aureus endocarditis.
Tsaganos T; Skiadas I; Koutoukas P; Adamis T; Baxevanos N; Tzepi I; Pelekanou A; Giamarellos-Bourboulis EJ; Giamarellou H; Kanellakopoulou K
J Antimicrob Chemother; 2008 Aug; 62(2):381-3. PubMed ID: 18445576
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of trovafloxacin in experimental endocarditis caused by ciprofloxacin-sensitive, methicillin-resistant Staphylococcus aureus.
Kim YS; Liu Q; Chow LL; Chambers HF; Täuber MG
Antimicrob Agents Chemother; 1998 Dec; 42(12):3325-7. PubMed ID: 9835540
[TBL] [Abstract][Full Text] [Related]
17. Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.
Climo MW; Patron RL; Goldstein BP; Archer GL
Antimicrob Agents Chemother; 1998 Jun; 42(6):1355-60. PubMed ID: 9624475
[TBL] [Abstract][Full Text] [Related]
18. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.
Siaperas P; Pefanis A; Iliopoulos D; Katsarolis I; Kyroudi-Voulgari A; Donta I; Karayiannakos P; Giamarellou H
Antimicrob Agents Chemother; 2001 Dec; 45(12):3531-7. PubMed ID: 11709335
[TBL] [Abstract][Full Text] [Related]
19. Oral temafloxacin versus vancomycin for therapy of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.
Hessen MT; Pitsakis PG; Kaye D
Antimicrob Agents Chemother; 1990 Jun; 34(6):1143-5. PubMed ID: 2393273
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus.
Chambers HF; Xiang Q; Liu ; Chow LL; Hackbarth C
Antimicrob Agents Chemother; 1999 Nov; 43(11):2742-6. PubMed ID: 10543757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]